The role of nicotine on respiratory sensory gating measured by respiratoryrelated evoked potentials

Journal of Applied Physiology

Volumn 108, Issue 3, 2010, Pages 662-669

  Chan, Pei Ying Sarah ^a   Davenport, P W ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Affective state; Anxiety; Load perception; Mechanosensation; Respiratory related evoked potential

Indexed keywords

NICOTINE; NICOTINIC AGENT;

ADULT; ANXIETY; ARTICLE; BRAIN CORTEX; BREATHING; CHEWING GUM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EVOKED RESPONSE; FEMALE; HUMAN; LUNG FUNCTION TEST; MALE; MECHANOTRANSDUCTION; METHODOLOGY; ORAL DRUG ADMINISTRATION; PATHOPHYSIOLOGY; PERCEPTION; PSYCHOLOGICAL ASPECT; RANDOMIZED CONTROLLED TRIAL; REACTION TIME; SENSORY GATING; SMOKING; SMOKING CESSATION; TIME; WITHDRAWAL SYNDROME;

ADMINISTRATION, ORAL; ANXIETY; CEREBRAL CORTEX; CHEWING GUM; ELECTROENCEPHALOGRAPHY; ELECTROOCULOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; MECHANOTRANSDUCTION, CELLULAR; NICOTINE; NICOTINIC AGONISTS; PERCEPTION; REACTION TIME; RESPIRATION; RESPIRATORY FUNCTION TESTS; SENSORY GATING; SMOKING; SMOKING CESSATION; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS; YOUNG ADULT;

EID: 77949604060     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00798.2009     Document Type: Article

References (54)

1. [Anon.] Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med152: 1107-1136, 1995.
2. Adler LE, Hoffer LD, Wiser A, Freedman R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. Am J Psychiatry 150: 1856-1861, 1993.
3. Adler LE, Hoffer LJ, Griffith J, Waldo MC, Freedman R. Normalization by nicotine of deficient auditory sensory gating in me relatives of schizophrenics. Biol Psychiatry 32: 607-616, 1992.
4. Adler LE, Olincy A, Cawthra E, Hoffer M, Nagamoto HT, Amass L, Freedman R. Reversal of diminished inhibitory sensory gating in cocaine addicts by a nicotinic cholinergic mechanism. Neuropsychopharmacology 24: 671-679, 2001.
5. Adler LE, Olincy A, Waldo M, Harris JG, Griffith J, Stevens K, Flach K, Nagamoto H, Bickford P, Leonard S, Freedman R. Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24: 189-202, 1998.
6. Adler LE, Pachtman E, Franks RD, Pecevich M, Waldo MC, Freedman R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biol Psychiatry 17: 639-654, 1982.
7. Ambrosini A, De Pasqua V, Afra J, Sandor PS, Schoenen J. Reduced gating of middle-latency auditory evoked potentials (P50) in migraine patients: anomer indication of abnormal sensory processing? Neurosci Lett 306: 132-134, 2001.
8. Arnfred SM, Eder DN, Hemmingsen RP, Glenthoj BY, Chen AC. Gating of the vertex somatosensory and auditory evoked potential P50 and the correlation to skin, conductance orienting response in. healthy men. Psychiatry Res 101: 221-235, 2001.
9. Balfour DJ, Fagerstrom KO. Pharmacology of nicotine and its therapeutic use in smoking cessation and neurodegenerative disorders. Pharmacol Ther 11: 51-81, 1996.
10. Bogaerts K, Notebaert K, Van Diest 1, Devriese S, De Peuter S, Van den Bergh O. Accuracy of respiratory symptom perception in different affective contexts. J Psychosom Res 58: 537-543, 2005.
11. Boutros NN, Gooding D, Sundaresan K, Burroughs S, Johanson CE. Cocaine-dependence and cocaine-induced paranoia and mid-latency auditory evoked responses and sensory gating. Psychiatry Res 145: 147-154, 2006.
12. Brockhaus-Dumke A, Schultze-Lutter F, Mueller R, Tendolkar I, Bechdolf A, Pukrop R, Klosterkoetter J, Ruhrmann S. Sensory gating in schizophrenia: P50 and N100 gating in antipsychotic-free subjects at risk, first-episode, and chronic patients. Biol Psychiatry 64: 376-384, 2008.
13. Bnujnzeel AW, Gold MS. The role of corticotropin-releasing factor-like peptides in cannabis, nicotine, and alcohol dependence. Brain Res Brain Res Rev 49: 505-528, 2005.
14. Chae Y, Yeom M, Han JH, Park HJ, Hahm DH, Shim I, Lee HS, Lee H. Effect of acupuncture on anxiety-like behavior during nicotine wimdrawal and relevant mechanisms. Neurosci Lett 430: 98-102, 2008.
15. Chan PY, Davenport PW. Respiratory-related evoked potential measures of respiratory sensory gating. J Appl Physiol 105: 1106-1113, 2008.
16. Chan PY, Davenport PW. Respiratory-related evoked potential measures of respiratory sensory gating in attend and ignore conditions. J Clin Neurophysiol 26: 438-445, 2009.
17. Cheeta S, Irvine E, File SE. Social isolation modifies nicotine's effects in animal tests of anxiety. Br J Pharmacol 132: 1389-1395, 2001.
18. Cook MR, Gerkovich MM, Graham C, Hoffman SJ, Peterson RC. Effects of the nicotine patch on performance during me first week of smoking cessation. Nicotine Tob Res 5: 169-180, 2003.
19. Corwin EJ, Klein LC. C-reactive protein and depressed mood in a sub-group of smokers during nicotine abstinence. Hum Psychopharmacol 18: 329-337, 2003.
20. Davenport PW, Colrain IM, Hill PM. Scalp topography of the shortlatency components of the respiratory-related evoked potential in children. J Appl Physiol 80: 1785-1791, 1996.
21. Davenport PW, Vovk A. Cortical and subcortical central neural pathways in respiratory sensations. Respir Physiol Neurobiol 2008.
22. Dixon L, Medoff DR, Wohlheiter K, DiClemente C, Goldberg R, Kreyenbuhl J, Adams C, Lucksted A, Davin C. Correlates of severity of smoking among persons with severe mental illness. Am J Addict 16: 101-110, 2007.
23. Domier CP, Mbnterosso JR, Brody AL, Simon SL, Mendrek A, Olmstead R, Jarvik ME, Cohen MS, London ED. Effects of cigarette smoking and abstinence on Stroop task performance. Psychopharmacology (Bert) 195: 1-9, 2007.
24. Domino EF, Kishimoto T. Tobacco smoking increases gating of irrelevant and enhances attention to relevant tones. Nicotine Tob Res 4: 71-78, 2002.
25. Duncan E, Madonick S, Chakravorty S, Parwani A, Szilagyi S, Efferen T, Gonzenbach S, Angrist B, Rotrosen J. Effects of smoking on acoustic startle and prepulse inhibition in humans. Psychopharmacology (Berl) 156: 266-272, 2001.
26. Grunwald T, Boutros NN, Pezer N, von Oertzen J, Fernandez G, Schaller C, Elger CE. Neuronal substrates of sensory gating within the human, brain. Biol Psychiatry 53: 511-519, 2003.
27. Guterman Y, Josiassen RC, Bashore TR Jr. Attentions influence on the P50 component of the auditory event-related brain potential. Int J Psychophysiol 12: 197-209, 1992.
28. Hetrick WP, Sandman CA, Bunney WE Jr, Jin Y, Potkin SG, White MH. Gender differences in gating of the auditory evoked potential in normal subjects. Biol Psychiatry 39: 51-58, 1996.
29. Hotting K, Rosier F, Roder B. Crossmodal and .intermodal attention modulate event-related brain potentials to tactile and auditory stimuli. Exp Brain Res 148: 26-37, 2003.
30. Hughes JR, Gust SW, Skoog K, Keenan RM, Fenwick JW. Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry 48: 52-59, 199.1.
31. Javanbakht A. Sensory gating deficits, pattern completion, and disturbed fronto-limbic balance, a model for description, of hallucinations and delusions in schizophrenia. Med Hypotheses 67: 1173-1184, 2006.
32. Jonkman S, Risbrough VB, Geyer MA, Markou A. Spontaneous nicotine withdrawal potentiates the effects of stress in rats. Neuropsychopharmacology 33: 2131-2138, 2008.
33. Kaitz SS, Robertson RT. Thalamic connections with limbic cortex. II. Corticothalamic projections. J Comp Neurol 195: 527-545, 1981.
34. Kisley MA, Olincy A, Freedman R. The effect of state on sensory gating: comparison of waking, REM and non-REM sleep. Clin Neurophysiol, 112: 1154-1165, 2001.
35. Krettek JE, Price JL. Projections from the amygdaloid complex to the cerebral cortex and thalamus in the rat and cat. J Comp Neurol, 111: 681-111, 1977.
36. Kumari V, Checkley SA, Gray JA. Effect of cigarette smoking on prepulse inhibition of the acoustic startle reflex in healthy male smokers. Psychopharmacology (Bert) 128: 54-60, 1996.
37. Kumari V, Cotter PA, Checkley SA, Gray JA. Effect of acute subcutaneous nicotine on prepulse inhibition of the acoustic startle reflex in healthy male non-smokers. Psychopharmacology (Bert) 132: 389-395, 1997.
38. Levin ED. Nicotinic systems and cognitive function. Psychopharmacology (Berl) 108: 417-431, 1992.
39. Ludewig S, Ludewig K, Geyer MA, Hell D, Vollenweider FX. Prepulse inhibition deficits in patients with panic disorder. Depress Anxiety 15: 55-60, 2002.
40. Martin LF, Kem WR, Freedman R. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia. Psychopharmacology (Berl) 174: 54-64, 2004.
41. Neylan TC, Fletcher DJ, Lenoci M, McCallin K, Weiss DS, Schoenfeld FB, Marmar CR, Fein G. Sensory gating in chronic posttraumatic stress disorder: reduced auditory P50 suppression in combat veterans. Biol Psychiatry 46: 1656-1664, 1999.
42. Olincy A, Stevens KE. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men. Biochem Pharmacol 74: 1192-1201, 2007.
43. Pineda JA, Herrera C, Kang C, Sandler A. Effects of cigarette smoking and 12-h abstention on working memory during a serial-probe recognition task. Psychopharmacology (Berl) 139: 311-321, 1998.
44. Postma P, Kumari V, Sharma T, Hines M, Gray JA. Startle response during smoking and 24 h after withdrawal predicts successful smoking cessation. Psychopharmacology (Berl) 156: 360-367, 2001.
45. Rentzsch J, Penzhorn A, Kernbichler K, Plockl D, Gomez-Carrillo de Castro A, Gallinat J, Jockers-Scherubl MC. Differential impact of heavy cannabis use on. sensory gating in. schizophrenic patients and otherwise healthy controls. Exp Neurol 205: 241-249, 2007.
46. Robertson RT, Kaitz SS. Thalamic connections with limbic cortex. I. Thalamocortical projections. J Comp Neurol 195: 501-525, 1981.
47. Rose JE, Benin FM, Salley AN, Bates JE, Coleman RE, Hawk TC, Turkington TG. Regional brain activity correlates of nicotine dependence. Neuropsychopharmacology 32: 2441-2452, 2007.
48. Sanchez-Mbrla EM, Garcia-Jimenez MA, Barabash A, MartinezVizcaino V, Mena J, Cabranes-Diaz JA, Baca-Baldomero E, Santos JL. P50 sensory gating deficit is a common, marker of vulnerability to bipolar disorder and schizophrenia. Acta Psychiatr Scand 117: 313-318, 2008.
49. Semenova S, Bespalov A, Markou A. Decreased prepulse inhibition during nicotine withdrawal in DBA/2J mice is reversed by nicotine self-administration. Eur J Pharmacol 427: 99-110, 2003.
50. Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience 133: 729-738, 2005.
51. Spielberger C. Manual for the State-Trait Anxiety Inventory (STAI). Palo Alto, CA: Consulting Psychologists, 1983.
52. Sripanidkulchai K, Sripanidkulchai B, Wyss JM. The cortical projection of the basolateral amygdaloid nucleus in the rat: a retrograde fluorescent dye study. J Comp Neurol 229: 419-431, 1984.
53. von Leupoldt A, Dahme B. Psychological aspects in the perception of dyspnea in obstructive pulmonary diseases. Respir Med 101: 411-422, 2007.
54. Webster KE, Colrain IM, Davenport PW. P300 from inspiratory occlusion reflects orienting but not startle. Biol Psychol, 66: 21-33, 2004.